Q32 Bio Inc. (QTTB) Net Income towards Common Stockholders (2017 - 2026)

Q32 Bio has reported Net Income towards Common Stockholders for 10 years, with the latest figure at -$8.9 million in Q2 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 5.72% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was $4.0 million, a 186.49% increase from a year earlier, with the FY2025 full-year figure at $29821.0, up 162.47% from the prior year.
• Net Income towards Common Stockholders was -$8.9 million for Q2 2026 at Q32 Bio, down from -$7.6 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $92.7 million in Q1 2022, with the low at -$31.6 million in Q3 2022.
• Average Net Income towards Common Stockholders over 5 years is -$800091.9, with a median of -$8.3 million recorded in 2026.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders soared 8735.88% in 2022, then sank 1172.01% in 2025.
• Over 5 years, Net Income towards Common Stockholders stood at -$30.9 million in 2022, then surged by 186.27% to $26.6 million in 2023, then gained by 25.82% to $33.5 million in 2024, then dropped by 16.59% to $27.9 million in 2025, then sank by 132.02% to -$8.9 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$8.9 million (Q2 2026), -$7.6 million (Q1 2026), and $27.9 million (Q4 2025), per Business Quant data.